These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20154279)

  • 1. PAX5 expression in nonhematopoietic tissues. Reappraisal of previous studies.
    Morgenstern DA; Hasan F; Gibson S; Winyard P; Sebire NJ; Anderson J
    Am J Clin Pathol; 2010 Mar; 133(3):407-15. PubMed ID: 20154279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX immunoreactivity identifies alveolar rhabdomyosarcoma.
    Sullivan LM; Atkins KA; LeGallo RD
    Am J Surg Pathol; 2009 May; 33(5):775-80. PubMed ID: 19145202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple isoforms of PAX5 are expressed in both lymphomas and normal B-cells.
    Arseneau JR; Laflamme M; Lewis SM; Maïcas E; Ouellette RJ
    Br J Haematol; 2009 Nov; 147(3):328-38. PubMed ID: 19725825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAX immunoreactivity in poorly differentiated small round cell tumors of childhood.
    Fan R
    Fetal Pediatr Pathol; 2014 Aug; 33(4):244-52. PubMed ID: 24897005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples.
    Agostinelli C; Sabattini E; Gjørret JO; Righi S; Rossi M; Mancini M; Piccaluga PP; Bacci F; Marafioti T; Bettini G; Falini B; Pileri SA
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):561-72. PubMed ID: 20697266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations.
    Hart MR; Anderson DJ; Porter CC; Neff T; Levin M; Horwitz MS
    PLoS Genet; 2018 Sep; 14(9):e1007642. PubMed ID: 30216339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
    Nasr MR; Rosenthal N; Syrbu S
    Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of PAX5 in oral carcinogenesis.
    Norhany S; Kouzu Y; Uzawa K; Hayama M; Higo M; Koike H; Kasamatu A; Tanzawa H
    Oncol Rep; 2006 Nov; 16(5):1003-8. PubMed ID: 17016584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors.
    Carpentieri DF; Nichols K; Chou PM; Matthews M; Pawel B; Huff D
    Mod Pathol; 2002 Oct; 15(10):1080-6. PubMed ID: 12379755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal PAX8 polyclonal antibody shows cross-reactivity with N-terminal region of PAX5 and is responsible for reports of PAX8 positivity in malignant lymphomas.
    Moretti L; Medeiros LJ; Kunkalla K; Williams MD; Singh RR; Vega F
    Mod Pathol; 2012 Feb; 25(2):231-6. PubMed ID: 22037256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PAX gene function during kidney tumorigenesis: a comparative approach].
    Béland M; Bouchard M
    Bull Cancer; 2006 Sep; 93(9):875-82. PubMed ID: 16980230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mRNA for a newly identified Pax5 exon is reduced in multiple myeloma.
    Borson ND; Lacy MQ; Wettstein PJ
    Mamm Genome; 2006 Mar; 17(3):248-56. PubMed ID: 16518692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoforms of Pax5 and co-regulation of T- and B-cells associated genes influence phenotypic traits of ascetic cells causing Dalton's lymphoma.
    Bharti B; Mishra R
    Biochim Biophys Acta; 2011 Dec; 1813(12):2071-8. PubMed ID: 21854813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia.
    Tiacci E; Pileri S; Orleth A; Pacini R; Tabarrini A; Frenguelli F; Liso A; Diverio D; Lo-Coco F; Falini B
    Cancer Res; 2004 Oct; 64(20):7399-404. PubMed ID: 15492262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: associations with B-cell antigen expression and myelomonocytic maturation.
    Gibson SE; Dong HY; Advani AS; Hsi ED
    Am J Clin Pathol; 2006 Dec; 126(6):916-24. PubMed ID: 17074681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children.
    Sadakane Y; Zaitsu M; Nishi M; Sugita K; Mizutani S; Matsuzaki A; Sueoka E; Hamasaki Y; Ishii E
    Br J Haematol; 2007 Jan; 136(2):297-300. PubMed ID: 17129225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation.
    Li X; Huang J; Luo X; Yang D; Yin X; Peng W; Bi C; Ren G; Xiang T
    Int J Biol Sci; 2018; 14(12):1686-1695. PubMed ID: 30416383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of nestin expression in pediatric tumors in the region of the kidney.
    Murphy AJ; Viero S; Ho M; Thorner PS
    Appl Immunohistochem Mol Morphol; 2009 Dec; 17(6):517-23. PubMed ID: 19417621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic uses of Pax5 immunohistochemistry.
    Feldman AL; Dogan A
    Adv Anat Pathol; 2007 Sep; 14(5):323-34. PubMed ID: 17717432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: a potential source of confusion? A study of 30 cases from the National Wilms Tumor Study Pathology Center.
    Ellison DA; Parham DM; Bridge J; Beckwith JB
    Hum Pathol; 2007 Feb; 38(2):205-11. PubMed ID: 17134738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.